Soulsome Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
About Soulsome Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madhuchhanda Bagchi and Pulak Bagchi serve as directors at the Company.
- CIN/LLPIN
U24100WB2021PTC243759
- Company No.
243759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Soulsome Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhuchhanda Bagchi  | Director | 15-Mar-2023 | Current |
| Pulak Bagchi | Director | 11-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Soulsome Pharmaceuticals.
Soulsome Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Soulsome Pharmaceuticals?
Unlock access to Soulsome Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sukhsagar Goods Private LimitedActive 17 years 2 monthsMadhuchhanda Bagchi and Pulak Bagchi are mutual person
- Arctic Vinimay Private LimitedActive 14 years 7 months
Madhuchhanda Bagchi and Pulak Bagchi are mutual person
- Bolero Sales Private LimitedActive 14 years 7 months
Madhuchhanda Bagchi and Pulak Bagchi are mutual person
- Soulsome Media And Entertainment Private LimitedActive 3 years 4 months
Pulak Bagchi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soulsome Pharmaceuticals?
Soulsome Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soulsome Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soulsome Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
